1 unchanged sentence
Issuer Purchases of Equity Securities
−Removed: The following table provides information about Cigna's share repurchase activity for the quarter ended March 31, 2022:
+Added: The following table provides information about Cigna's share repurchase activity for the quarter ended June 30, 2022:
Period Total # of shares purchased (1)
5 unchanged sentences
of publicly announced program (3)
−Removed: January 1-31, 2022 2,212,194 $ 235.00 2,211,981 $ 4,643,127,370
−Removed: February 1-28, 2022 3,587,937 $ 227.40 3,368,771 $ 9,877,331,055
−Removed: March 1-31, 2022 299,880 $ 236.26 202,830 $ 9,829,417,680
+Added: April 1-30, 2022 1,519,764 $ 253.80 1,517,385 $ 9,444,290,632
+Added: May 1-31, 2022 1,605,175 $ 260.50 1,604,582 $ 9,026,293,505
+Added: June 1-30, 2022 793,253 $ 256.02 792,733 $ 8,823,335,866
Total 3,918,192 $ 256.99 3,914,700 N/A
1 unchanged sentence
1) payment of taxes on vesting of restricted stock (grants and units) and strategic performance shares and 2) payment of the exercise price and taxes for certain stock options exercised.
−Removed: Employees tendered 213 shares in January, 219,166 shares in February and 97,050 shares in March 2022.
+Added: Employees tendered 2,379 shares in April, 593 shares in May and 520 shares in June 2022.
(2) Additionally, the Company maintains a share repurchase program authorized by the Board of Directors.
3 unchanged sentences
The program may be suspended or discontinued at any time and does not have an expiration date.
−Removed: In February 2022, the Board increased repurchase authority by an additional $6.0 billion.
−Removed: From April 1, 2022 through May 5, 2022, the Company repurchased 1.9 million shares for approximately $470 million.
−Removed: Share repurchase authority was $9.4 billion as of May 5, 2022.
+Added: From July 1, 2022 through August 3, 2022, we repurchased 10.4 million shares through the initial delivery under the ASR agreements discussed in the Liquidity and Capital Resources section of Management's Discussion and Analysis of Financial Condition and Results of Operations in Part I, Item 2.
+Added: Such repurchases were made pursuant to the Company's share repurchase program described above.
+Added: Share repurchase authority was $5.3 billion as of August 3, 2022.
(3) Approximate dollar value of shares is as of the last date of the applicable month.
1 unchanged sentence
Number Description Method of Filing
+Added: 10.1 Revolving Credit and Letter of Credit Agreement, dated as of April 28, 2022 , with the banks named therein, JPMorgan Chase Bank, N.A., as administrative agent, BofA Securities, Inc., Citibank, N.A., Morgan Stanley Senior Funding, Inc., MUFG Bank, LTD and Wells Fargo Securities, LLC, as joint lead arrangers and joint bookrunners
+Added: Filed by the registrant as Exhibit 10.1 to the Current Report on Form 8-K on April 29, 2022 and incorporated herein by reference.
31.1 Certification of Chief Executive Officer of Cigna Corporation pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
6 unchanged sentences
Furnished herewith.
−Removed: 101 The following materials from Cigna Corporation's Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, formatted in inline XBRL (eXtensible Business Reporting Language):
+Added: 101 The following materials from Cigna Corporation's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in inline XBRL (eXtensible Business Reporting Language):
(i) the Consolidated Statements of Income;
7 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: August 4, 2022
CIGNA CORPORATION
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.